GT Biopharma, Inc. - GTBP

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$641K
QoQ value delta ($000)
+$284K (+79.55%)
Implied price effect (QoQ)
-46.24%
Shares
Total shares
1,613,172
QoQ shares delta
+1,130,161 (+233.98%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (GTBP)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Early Q2 2026 data: only 59 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD CAPITAL MANAGEMENT LLC 184 451,875 0.0%
GEODE CAPITAL MANAGEMENT, LLC 120 294,459 0.0%
VANGUARD FIDUCIARY TRUST CO 92 225,938 0.0%
Arax Advisory Partners 38 93,627 0.0%
CITADEL ADVISORS LLC 27 66,165 0.0%
SeaCrest Wealth Management, LLC 20 50,000 0.0%
UBS Group AG 18 45,970 0.0%
LPL Financial LLC 12 30,382 0.0%
TWO SIGMA SECURITIES, LLC 12 31,796 0.0%
Invst, LLC 9 23,400 0.0%
Keel Point, LLC 8 20,768 0.0%
Cerity Partners LLC 8 20,023 0.0%
OSAIC HOLDINGS, INC. 8 21,000 0.0%
Integrated Wealth Concepts LLC 8 20,006 0.0%
Private Wealth Management Group, LLC 8 20,000 0.0%
WELLS FARGO & COMPANY/MN 6 16,037 0.0%
MORGAN STANLEY 6 16,599 0.0%
StoneX Group Inc. 6 14,756 0.0%
Virtu Financial LLC 6 14,876 0.0%
AM INVESTMENT STRATEGIES LLC 6 15,000 0.0%
Coston, McIsaac & Partners 6 17,092 0.0%
Caitlin John, LLC 6 16,500 0.0%
PARSONS CAPITAL MANAGEMENT INC/RI 4 10,900 0.0%
Prospera Financial Services Inc 4 11,996 0.0%
Verdence Capital Advisors LLC 4 12,000 0.0%